PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26123N0681Cinryze — Takeda Pharmaceuticals America, Inc

Takeda Pharmaceuticals America, Inc holds $6.5M across 96 federal awards, concentrated at Department of Justice (DOJ). This PIID sits alongside 4 related awards under parent V797D50492. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Aug 21, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

261-Network Contract Office 21 (36C261)
Awarding office
Takeda Pharmaceuticals America, Inc
Recipient
Aug 21, 2023
PoP end
$511K
Obligated
$511K
Potential
325412
NAICS
6505
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Takeda Pharmaceuticals America, Inc — $90

Contract facts

Federal
Contract number36C26123N0681
Also listed as36C261-23-N-0681
Also listed asV797D50492-36C26123N0681
Agency261-Network Contract Office 21 (36C261)
Awarding office261-Network Contract Office 21 (36C261)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentTakeda Pharmaceuticals America, Inc
CAGE4DE70
UEIDDEVYUAXJ624
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDVV797D50492
Place of performanceLEXINGTON MA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startJun 20, 2023
PoP end (current)Aug 21, 2023
Obligated$511K
Current value$511K
Potential value$511K

CINRYZE is a federal award for 261-Network Contract Office 21 (36C261) held by Takeda Pharmaceuticals America, Inc. Estimated value $511K ($511K obligated). Current period of performance ends Aug 21, 2023. Last award drew 1 bidder. Place of performance: LEXINGTON MA.

Recompete timing

Public
Past PoP end (1096 days ago)

Current PoP ended Aug 21, 2023 (1096 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Takeda Pharmaceuticals America, Inc$6.5M obligated across 96 awards (firm-wide, all agencies) · lead buyer Department of Justice (DOJ).

% of firm-wide obligated ($6.5M) · all agencies
Department of Justice (DOJ)$4.0M · 62%Department of Veterans Affairs (VA)$2.5M · 38%Department of Defense (DOD)$20K · 0%
Open full company profile

Related awards

Same parent · incumbent
15B50926F00000076
FY26 PHARMACEUTICALS TAKEDA APRIL-SEPTEMBER
$549K
Sep 30, 2026
15B50926F00000018
FY26 TAKEDA OCT-NOV
$320K
Sep 30, 2026
36C26026P0420
GAMMAGARD LIQUID ERC - GLOBULIN,IMMUNE (IV) 10% INJ
$108K
Sep 30, 2026
36C26026F0130
ADZYNMA 1500IU INJ,LYPHL.
$179K
Jan 3, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26123N0681?

36C26123N0681 (Cinryze) is a 261-Network Contract Office 21 (36C261) award with a potential value of $511K, currently held by Takeda Pharmaceuticals America, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C261-23-N-0681?

36C261-23-N-0681 is the dashed form of PIID 36C26123N0681 (Cinryze), held by Takeda Pharmaceuticals America, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26123N0681?

261-Network Contract Office 21 (36C261) awarded 36C26123N0681 to Takeda Pharmaceuticals America, Inc (potential $511K).

Who is the incumbent on 36C26123N0681?

Takeda Pharmaceuticals America, Inc is the incumbent with $6.5M across 96 related awards in SCOUT’s public footprint. The current period of performance ends Aug 21, 2023.

When does Takeda Pharmaceuticals America, Inc’s 36C26123N0681 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 21, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26123N0681